휴온스글로벌

084110KOSDAQ의약품 제조업

57.8 / 100

Reference Date: 2026-07-24

Financial Score23.5 / 40

News Sentiment17.3 / 25

Momentum7.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers but Operating Profit is on a declining trend. Rose 5.3% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Hyunohs Global is a holding company under the Hyunohs Group, managing 13 subsidiaries across pharmaceuticals, medical devices, biopharmaceuticals, and health supplements. Key operations include Hyunohs' pharmaceutical manufacturing, Hyunmedics' botulinum toxin and filler development, Hyunohs Biopharma's biopharmaceutical research, and Hyunohs Meditech's medical device production. Primary revenue streams include brand royalties and dividends from subsidiaries.

Number of Employees

121people

Average Salary

62.0M KRW

Score Calculation Basis

Detailed Financial Score

PER

10.92Industry Average 11.235.0Point

In line with industry avg

PBR

0.30Industry Average 0.817.0Point

Half of industry avg (excellent)

ROE

7.96Industry Average 4.015.5Point

2.0x industry avg (good)

Debt Ratio

13.66Industry Average 12.432.0Point

Higher than industry avg (caution)

Trend 2023~20254.0 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲5.7% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼10.8% (2-year basis)

ROE Trend

2.0 / 4

Avg ROE 8.7% (declining, 3yr)

Detailed News Sentiment

7 totalPositive 3Neutral 2Negative 2Average Sentiment Score 69.3

Neutral
중복상장 가이드라인 확정…휴온스글로벌, 임시주총 '3%룰' 저울질
금융당국의 중복상장 가이드라인 발표로 인해 휴온스글로벌의 구체적인 영향은 불확실함.
Positive
휴온스메디텍 "의료기기 매출 70%로 확대"
휴온스메디텍의 의료기기 매출 확대 계획 발표로 인해 회사의 성장 잠재력이 높게 평가되며 긍정적인 시장 반응 예상.
Neutral
휴온스·휴온스랩, 합병 '우회상장' 심사 시험대
금융당국의 중복상장 규제 강화로 휴온스와 휴온스랩의 합병 과정에 불확실성이 증가했다.

Detailed Momentum

52-week position1.0Point

Near 52w low (6%, downtrend)

Current 25,850Won52-week high 75,30052-week low 22,550

1-month return4.0Point

1m +5.30% (slight rise)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral지속가능경영보고서등관련사항(자율공시)2026-06-26
Neutral[기재정정]타인에대한채무보증결정(자회사의 주요경영사항)2026-06-26